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Campuses  
Abstract  
Background 
Psychostimulants are widely misused on college campuses for recreation and academic 
gain, but many students are not aware of the impact of these drugs on mental health. Literature 
proposes psychostimulant use decreases the availability of dopamine receptors, thus promoting 
symptoms of mental distress. The purpose of this study is to assess the physical and mental 
symptoms of misuse, identify the populations at risk of misusing psychostimulants, and to 
deduce the most effective approaches to persuade users about the adverse effects of misuse. 
Methods 
An anonymous electronic survey was distributed to 596 college students in the 
Northeastern United States assessing demographics, perception of safety, frequency of use and 
mental health status. This survey was advertised on social media platforms, campus flyers, and 
tabling events. Pearson’s Correlation Coefficient and Principal Component Analysis (PCA) were 
used to analyze data in SPSS version 25.0. 
Results 
Misusing psychostimulants is significantly correlated with higher levels of mental 
distress such as anxiety, depression, panic attacks, irritability, and suicidal thoughts. Risk factors 
for psychostimulant misuse include Greek life affiliation, age, and GPA. Participants stated that 
education via real life stories and mechanistic illustrations of negative physiological side effects 
would dissuade future misuse of psychostimulants. 
Conclusions 
Our research agrees with the literature connecting psychostimulant misuse and mental 
distress. This study provides insights to support informational sessions on college campuses to 
diminish the abuse of ADHD medications by college students. Efforts should be directed to 
educating the risky populations such as social science majors and Greek life organizations. 
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Introduction 
The non-prescription use of Attention-Deficit/Hyperactivity Disorder (ADHD) 
psychostimulant medications such as Adderall, Ritalin, and Vyvanse is a prevalent and urgent 
issue impacting college students, yet research on the issue is limited. Studies report a range of 
17% to 43% of American college students have used ADHD medications for non-medicinal 
purposes (Benson et al., 2015; DeSantis, Webb, and Norr, 2008). 
Attention-Deficit/Hyperactivity Disorder (ADHD) 
 
ADHD is a neurobehavioral disorder defined by symptoms of inattention and hyperactive 
impulses (American Psychiatric Association, 2000). The condition typically commences during 
childhood and about 50% of cases continue into adulthood (Wilens et al., 2004). Many of the 
symptoms of the disorder are due to disrupted or dysregulated dopamine neurotransmission in 
the central nervous system (Misener et al., 2004). Low levels of dopamine culminate in 
decreased motivation from the reward system; this is why patients with ADHD struggle to 
sustain attention on goal-oriented behaviors. 
A dysfunctioning prefrontal cortex (PFC) also plays a key role in the cause of ADHD 
symptoms (Spencer, et al. 2015). The PFC plays a key role in maintaining attention assigning 
significance to the subject matter. The PFC also filters out distractions, shifting focus, and 
organizing thoughts and behaviors to achieve goals. In addition, the PFC regulates hyperactivity 
via the area’s ability to regulate inappropriate emotions, impulses, and behaviors. Genetic 
linkage studies display that ADHD is associated with decreased dopamine release in the PFC 
(Castellanos, 2001). Small changes in dopamine concentrations in the PFC can excite the 
pyramidal cells and have marked effects on PFC function (Arnsten, 2009), disrupting the PFC’s 
attention and hyperactivity regulation abilities. In patients with ADHD, neuroimaging displays 
anatomical alterations which would effectively decrease dopaminergic function in dopamine-rich 
portions of the brain like the PFC (and the striatum) (Castellanos, 2001).​  
Psychostimulant use for ADHD and Drug Mechanism 
Along with behavioral therapy, a common and effective treatment for ADHD (as well as 
other CNS conditions such as narcolepsy) is the prescription of medications such as Adderall® 
(mixed salt amphetamine), Ritalin® (methylphenidate), Vyvanse® (lisdexamfetamine 
dimesylate) and Dexedrine®(dextroamphetamine). These compounds increase monoamine 
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neurotransmitter release in areas of the brain like the PFC and striatum, thus effectively treating 
symptoms of inattentively and impulsivity prominent in cases of ADHD. The efficacy of these 
medications for the use of treating ADHD have been confirmed (Gross, 1976; Greenhill et al., 
2003, Faraone et al., 2006). 
The most commonly prescribed psychostimulant to treat ADHD is Adderall, which is 
amphetamine-based. The chemical structure of amphetamines dictates its function. The planar 
geometry, small molecular size, aromatic rings, and a Nitrogen on the aryl side chain are 
structural qualities similar to that of neurotransmitter monoamines. These monoamines include 
catecholamine neurotransmitters such as dopamine, serotonin, and noradrenaline (Holmes & 
Rutledge, 1976). Due to its similar molecular structure to monoamines, amphetamines enter the 
cell through dopamine transporters, and proceed to alter the function of monoamine transporters 
like noradrenaline transporter (NET), dopamine transporter (DAT), and serotonin transporter 
(SERT), as well as vesicular monoamine transporter 2 (VMAT2) to reverse transport 
monoamines. The combined outcome is “reverse-transport:” reuptake transporters excessively 
pump neurotransmitters from the presynaptic neuron cytoplasm and storage vesicles into the 
synapse, rather than from the synapse back into the presynaptic neuron (Robertson et al., 2009). 
The other most common drug used to treat ADHD is methylphenidate (Ritilan®). 
Methylphenidate acts through a similar method compared to amphetamines of increasing 
synapse concentrations of catecholamine neurotransmitters in the synapse. The drug contrasts 
from amphetamines by blocking reuptake of the neurotransmitters, rather than causing efflux of 
neurotransmitters. (Kuczenski & Segal, 2002). Regardless, the effect is similar to that of 
amphetamines: an increase of neurotransmitters in the CNS. 
The flooding of the CNS with these monoamines stimulates the catecholamine-deficient 
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regions of the PFC and striatum in patients with ADHD. The result is increased attention, focus, 
and decrease in impulsive behaviors. This same mechanism of neurotransmitter release causes 
the feeling of euphoria and increased motivation in non-ADHD individuals. This “high” 
encourages the recreational use of the psychostimulants and is one of the primary reasons for the 
misuse of these medications.​  
Misuse of ADHD Medications 
Today in the United States, the misuse of ADHD medications is on the rise in the college 
student population. Students who misuse ADHD medications report doing so due to the increase 
in attention and cognition they report to have while on the drug. Despite this perception, ADHD 
medication use in non-ADHD individuals is negatively related with GPA (Begdache et al., 
2019). Additional evidence suggests that non-prescription use of ADHD drugs has no significant 
effect on attention (Repantis et al., 2010). These medications may also inhibit cognitive abilities 
such as cognitive flexibility and decision making (Smith & Farah, 2011). Conversely, other 
studies found small to moderate increase in function of working-memory, delayed memory and 
processing speed (response-time) in individuals who were administered small doses of 
amphetamines (Ilieva et al., 2015). Possible proposed explanations for these improvements were 
the placebo effect, or an increase in motivation (resulting from the release of dopamine upon 
intake of amphetamines) (Weyandt et al., 2016).​  
Effects of Long-term Misuse​  
The US Drug Enforcement Agency (DEA) classifies ADHD medications as Schedule II 
drugs due to their potential for addiction, dependency, and abuse. Other Schedule II drugs 
include cocaine, pain medications such as opium and OxyContin, and Phencyclidine (PCP) 
(United Stated Department of Justice, DEA, 2017). Despite the legal implications and potential, 
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students continue to abuse these medications illicitly (without a prescription from a licensed 
physician). As stated before, psychostimulants are widely considered safe for individuals to 
consume when given the proper dosage, and even children are prescribed the medications at a 
young age. The perceived safety of these medications has contributed to the normalization and 
increase in prevalence of psychostimulant misuse on college campuses (DeSantis & Hein, 2009). 
But the use of psychostimulants for recreation or academic benefit by individuals who do not 
have ADHD can have long-term adverse effects. 
Most of the long-term adverse effects stem from dopamine dysregulation. Ricaurte et. al 
(2005) describes a decrease in striatal dopamine up to 30-50% in primates treated with doses of 
Adderall mimicking those in human clinical treatment. Other research describes a 
downregulation of dopamine receptor (D2/3) availability due to amphetamine-based 
psychostimulants like Adderall (Schrantee, et al., 2017). Downregulation of dopamine receptors 
is linked to anxiety, depression, nervousness, loss of motivation, and psychosis (Varga, 2012). 
Amphetamine abusers also exhibit deficits in decision-making cognition, which is hypothesized 
to be connected to the dysregulation of dopamine in the PFC (Rodgers, 1999). Given the delayed 
development of the PFC, college students are particularly vulnerable to developing psychiatric 
disorders related to PFC dysfunction (i.e. depression, anxiety, schizophrenia). Environmental 
factors like illicit stimulant use has been evidenced to exacerbate these risks by dysregulating 
dopamine in the developing brain (Paus, 2008). 
In essence, many students who illicitly use non-prescription ADHD medications are 
uninformed or misinformed about the physical and mental impacts of these medications. The 
purpose of this study is to identify and classify patterns of physical and mental symptoms of 
misuse, classify perceived safety of the drug, determine populations at risk of misusing Adderall, 
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and to deduce the most effective approaches to persuade users about the adverse effects of 
misuse. 
Methods 
The Institutional Review Board at Binghamton University Human Subjects Research 
Review Committee reviewed and approved the study protocol. Inclusion criteria included being 
18 years or older and being enrolled in a US college. The anonymous survey was built in Google 
Forms and the link was sent through social media platforms requesting responses from US 
college students. ​Participants gave consent to the study by accessing the survey. For Binghamton 
University data collection, the survey was shared on social media and advertised at tabling 
events on campus and no compensation was provided for participation. ​A total of 596 individuals 
completed the survey. The latter included a total of 40 questions addressing demographics, 
psychostimulant use, perceptions of psychostimulant safety, and potential methods to dissuade 
psychostimulant use. Responses were on a 6 likert-scale​.​ In this survey, psychostimulants were 
first listed as “such as, but not limited to; Adderall, Ritalin, Concerta, or Vyvanse”. Data were 
analyzed by employing Pearson’s Correlation Coefficient and a Principal Component Analysis 
(PCA). The PCA was used to identify patterns in the data set that associate with the different 
beliefs and ​patterns of behaviors within the data set, which are important to understanding the 
reason behind misuse of psychostimulants. ​Sampling adequacy and inter-correlation of variables 
were assessed using Kaiser-Meyer-Olkin (KMO) test and Bartlett’s test of sphericity, 
respectively.  ​To determine the number of principal components (PCs) retained, eigenvalue >1.0 
criterion was used​. A factor loading of 2.0 or more was considered. Additionally, the number of 
PCs selected was confirmed by visually examining the screen plot. ​PCs were then orthogonally 
rotated (varimax) to simplify and enhance their interpretability. ​All data were analyzed using 
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SPSS version 25.0.  
Results 
Demographics 
Participants (n=596) self-reported sex, age, Greek life affiliation, ethnicity, and location 
of their college (Table 1).  
Unprescribed psychostimulant use 
Non-prescription psychostimulant misuse was positively correlated with social 
fraternities/sororities affiliation, social science majors, economics majors, males, alcohol 
consumption more than twice a week, recreational painkiller use, and low GPA. Hard science 
majors and participants without Greek affiliation were negatively correlated with 
non-prescription psychostimulant misuse.  
Those who obtained unprescribed psychostimulants illegally were positively correlated 
with receiving it from a fraternity or sorority member (p<0.05) and negatively correlated with 
receiving it from a friend (p<0.05) (Table 2). 
Side Effects 
Those who used unprescribed psychostimulants reported panic attacks, weight loss, 
inability to concentrate, anxiety, irritability, depression, fatigue, headache, aggression, paranoia, 
lack of motivation, mood swings, sleep difficulty, and suicidal thoughts during use of 
unprescribed psychostimulants (Table 3).  
Perceived Safety 
Principal Component Analysis (PCA) identified 2 components: (1) Perception of 
psychostimulants safety and (2) Pattern for frequent users of psychostimulants. Component 1 
reflects a pattern of perception that alcohol, marijuana, prescription painkillers, and caffeine as 
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less safe than psychostimulants and that those individuals would not be dissuaded by the 
negative psychological and psychological effects of psychostimulants. Component 2 reflects a 
pattern of frequent psychostimulant users who believe that psychostimulant is equally as safe as 
alcohol and prescription painkillers and that psychostimulants are safer than cocaine. Component 
2 reveals that frequent psychostimulant users are stressed at least once a week and negative 
psychological and physiological effects would not be a strong enough motivator to dissuade use 
of psychostimulant. 
Education 
As for the educational outreach approaches, survey participants stated that sharing real 
life stories (38.9%) and negative side effects (35.9%) would be likely to dissuade their personal 
unprescribed psychostimulant use. 
Discussion 
The purpose of this study was to assess the relationship between psychostimulant use and 
overall mental health of college students. Particularly, this study focused on the adverse mental 
health effects potentially caused by unprescribed use of psychostimulants. The main findings of 
this study are: 1) Psychostimulants highly correlate with reports of adverse side effects and 2) 
Specific subpopulations of students including psychology majors and Greek affiliated students 
are more likely to misuse psychostimulants. The effects of prescription stimulants on mental 
wellbeing have been fairly well documented from a pharmacological perspective. Due to 
fluctuations in monoamine regulation, individuals who take psychostimulants regularly often 
report feelings of depression and anxiety (Sherzada, 2011). To evaluate mental health, 
participants were asked to report all adverse effects experienced from both prescribed and 
unprescribed use of psychostimulants. In accordance with the literature, our results did reveal a 
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number of adverse side effects with regard to mental health of the user. Ailments such as panic 
attacks, aggression, paranoia, weight loss, irritability, anxiety, suicidal thoughts, and lack of 
motivation all strongly correlated with psychostimulant use. Along with the current literature, 
these findings are extremely concerning when we consider the breadth of psychostimulant use 
across college campuses.  
A secondary aim of the present study was to identify subpopulations of college students 
most at risk for this epidemic as well as general perceptions of psychostimulant use. The major 
findings from our survey suggest that students in social science majors such as psychology and 
economics are most likely to be using non-prescription psychostimulants. Before assuming that 
psychology and economics majors are the most at risk, however, it is important to test group 
difference between majors. In addition to use risk with respect to major, data showed that the 
most at-risk groups of users reside within the Greek life community. Our results revealed that 
there was a prominent correlation between non-prescription psychostimulant use and 
membership in a fraternity or sorority. Out of those users belonging to the aforementioned 
demographic, many reported acquiring the medication from another member of their fraternity or 
sorority. These findings align with McCabe et al. (2004) who described that Adderall use was 
correlated with membership in a social fraternity/sorority. Despite support from literature in the 
field, it is important to consider the impacts of selection bias on this survey.  
Another concerning finding was the degree to which individuals use other drugs in 
addition to the non-prescription psychostimulant use. Drinking alcohol more than twice a week 
as well as recreational painkiller use correlates with non-prescription psychostimulant use. It is 
possible that psychostimulant abuse may prime the brain for further substance use, hence, 
individuals using these medications are more likely to use other drugs and engage in risky 
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behavior (Jardin et al., 2011). 
A major contributing factor to the epidemic of non-prescription psychostimulant use 
potentially revolves around the perceived safety of these types of drugs by college students. Our 
data shows that a significant number of participants reported perceiving psychostimulants as 
safer to use than prescription painkillers. In fact, the data suggests that many college students are 
not aware nor educated about the risks associated with non-prescription psychostimulant use. 
This notion of perceived safety largely ties into the Health Belief Model created in the 1950s 
(Rosenstock et al., 1988). The Health Belief Model hypothesizes that health-related action is 
largely reliant on three factors: 1) Sufficient motivation to make a particular issue relevant, 2) 
The belief that one truly is vulnerable to a particular health threat, and 3) The belief that 
following a particular recommendation would be beneficial in preventing illness. With regard to 
perceived safety, it is imperative to consider point (2) of the Health Belief Model. To elaborate, 
it is very likely that college students who are not educated about psychostimulants do not 
perceive themselves to be vulnerable to the negative side effects of these drugs. As a result, some 
students may have the inherent belief that they are immune to the negative consequences of 
psychostimulants misuse. To combat this, it is imperative to reallocate university budgets in 
order to create programming that informs students about not only alcohol and marijuana, but also 
the dangers of psychostimulant misuse​.​ When asked about prevention measures, participants 
reported that education via real life stories and illustrations of adverse side effects would be most 
likely to dissuade use. With regard to point (3) of the Health Belief Model, these findings suggest 
that true stories of the dangers of Adderall and similar drugs may encourage college students to 
be more open to listening to recommendations from health professionals. By implementing these 
measures in seminars and other information sessions, abuse of psychostimulants by college 
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students may be reduced. Our data suggest that it is imperative to​ ​specifically target at risk 
groups such as social science majors and Greek life organizations.  
Conclusion 
In summary, the current study reports that college students who illicitly used 
psychostimulants experienced symptoms of mental distress, such as depression, anxiety, and 
panic attacks. These findings are of great importance because hundreds of college students abuse 
psychostimulants yearly without knowledge of the implications. Without a proper education 
concerning psychostimulants, these students risk damaging their mental and physical health in a 
futile effort to excel in academics via medication misuse. Despite these efforts to boost academic 
performance, data revealed a negative relationship between illicit 
psychostimulant use and GPA. Additionally, mental distress, which may be caused by 
substance misuse is linked to lower academic performance. This conclusion along with other 
findings support the need for educational interventions to dissuade at risk students from illicit 
psychostimulant use. 
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Table 1. ​Showing demographic breakdowns of survey participants. N=596. * denotes p<0.05.  
**denotes p<0.01 
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Table 2. ​Showing correlation values for unprescribed psychostimulant use with various 
demographics. N=596. * denotes p<0.05. **denotes p<0.01 
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Table 3. ​Showing correlation values for unprescribed psychostimulant use with symptoms. 
N=596. * denotes p<0.05. **denotes p<0.01 
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Table 4.​ Principal Component Analysis (PCA) with varimax rotation. Principal components 
loading for A) perception of psychostimulant safety, B) frequency of psychostimulant use 
patterns. 
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